Reduction in hospitalization rates following cardiac resynchronisation therapy in cardiac failure: experience from a

Lana J Dixon1, J Gerry Murtagh, S Geoff Richardson

  • 1Regional Cardiology Centre, Belfast City Hospital, Northern Ireland. l.dixon@qub.ac.uk

Insights

Cardiac resynchronisation therapy (CRT) significantly improves heart failure symptoms and exercise capacity. This treatment drastically reduces hospitalizations and associated costs for patients with congestive cardiac failure (CCF).

Area of Science:

  • Cardiology
  • Medical Devices

Background:

  • Congestive cardiac failure (CCF) leads to frequent, prolonged hospitalizations, incurring substantial healthcare expenses.
  • Cardiac resynchronisation therapy (CRT) is an emerging treatment for CCF patients with cardiac conduction abnormalities.

Purpose of the Study:

  • To evaluate the impact of CRT on New York Heart Association (NYHA) symptom class, exercise tolerance, and hospitalization rates in CCF patients.

Main Methods:

  • A single-center study involving 27 patients who received CRT.
  • NYHA class, exercise tolerance (6-minute hall walk test), and hospitalization rates were recorded for 12 months pre- and post-CRT.

Main Results:

  • NYHA class improved significantly (P < 0.05), and exercise tolerance increased by 64% (P = 0.007).
  • Hospital days for CCF stabilization decreased by 98% (P < 0.001), resulting in significant cost savings.

Conclusions:

  • CRT offers substantial clinical benefits for CCF patients, including improved symptoms and exercise capacity.
  • CRT leads to considerable reductions in hospital admissions and healthcare costs for individuals with congestive cardiac failure.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...